实用心脑肺血管病杂志
實用心腦肺血管病雜誌
실용심뇌폐혈관병잡지
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
2015年
8期
60-61
,共2页
霍本良%潘庆丽%吕长泳%姜威峰%蒋杞英
霍本良%潘慶麗%呂長泳%薑威峰%蔣杞英
곽본량%반경려%려장영%강위봉%장기영
冠心病%胆固醇,HDL%介入疗法%预后
冠心病%膽固醇,HDL%介入療法%預後
관심병%담고순,HDL%개입요법%예후
Coronary disease%Cholesterol,HDL%Interventional therapy%Prognosis
目的：探讨高密度脂蛋白胆固醇（ HDL-C）水平对冠心病患者介入治疗术后不良心血管事件的影响。方法选择开封市第二人民医院心内科2013年2月—2014年2月收治的行介入治疗的冠心病患者113例，按照介入治疗前HDL-C水平分为低水平组（HDL-C<1.32 mmol/L）57例和高水平组（HDL-C≥1.32 mmol/L）56例，均随访观察12个月，记录两组患者术后不良心血管事件发生情况。结果两组患者均获得完全随访，随访率为100.0%。随访期间低水平组患者不良心血管事件发生率为31.6%，高于高水平组的16.1%（χ2=6.115，P =0.023）。结论HDL - C水平较高的冠心病患者介入治疗术后不良心血管事件发生率较低。
目的：探討高密度脂蛋白膽固醇（ HDL-C）水平對冠心病患者介入治療術後不良心血管事件的影響。方法選擇開封市第二人民醫院心內科2013年2月—2014年2月收治的行介入治療的冠心病患者113例，按照介入治療前HDL-C水平分為低水平組（HDL-C<1.32 mmol/L）57例和高水平組（HDL-C≥1.32 mmol/L）56例，均隨訪觀察12箇月，記錄兩組患者術後不良心血管事件髮生情況。結果兩組患者均穫得完全隨訪，隨訪率為100.0%。隨訪期間低水平組患者不良心血管事件髮生率為31.6%，高于高水平組的16.1%（χ2=6.115，P =0.023）。結論HDL - C水平較高的冠心病患者介入治療術後不良心血管事件髮生率較低。
목적：탐토고밀도지단백담고순（ HDL-C）수평대관심병환자개입치료술후불양심혈관사건적영향。방법선택개봉시제이인민의원심내과2013년2월—2014년2월수치적행개입치료적관심병환자113례，안조개입치료전HDL-C수평분위저수평조（HDL-C<1.32 mmol/L）57례화고수평조（HDL-C≥1.32 mmol/L）56례，균수방관찰12개월，기록량조환자술후불양심혈관사건발생정황。결과량조환자균획득완전수방，수방솔위100.0%。수방기간저수평조환자불양심혈관사건발생솔위31.6%，고우고수평조적16.1%（χ2=6.115，P =0.023）。결론HDL - C수평교고적관심병환자개입치료술후불양심혈관사건발생솔교저。
Objective To explore the impact of HDL-C level on adverse cardiac events in coronary heart disease patients treated by interventional therapy. Methods From February 2013 to February 2014,a total of 113 coronary heart disease patients were selected in the Department of Cardiology,the Second People′s Hospital of Kaifeng,and they were divided into A group(HDL-C<1. 32 mmol/L,n=57)and B group(HDL-C≥1. 32 mmol/L,n=56)according to HDL-C level before interventional therapy. Patients of both groups were fellowed up for 12 months,and the incidence of adverse cardiac events was recorded. Results All of the patients were successfully followed up,the follow-up rate was 100. 0%. The incidence of adverse cardiac events of A group was 31. 6%,was statistically significantly higher than that of B group of 16. 1%(χ2 =6. 115, P=0. 023). Conclusion Coronary heart disease patients with increased HDL-C level have low risk of adverse cardiac events after interventional therapy.
